A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
| Image |  |
|---|---|
| Description | scientific article published on 20 January 2015 |
| Author/s |
author: Christian Senft |
| Publication date | January 20, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |